Funding

Dr. Windebank's Regenerative Neurobiology Laboratory receives funding from a variety of sources.

Grants

Investigator & Role Grant Title Funding Source Duration
Anthony J. Windebank, M.D., principal investigator Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1) National Center for Advancing Translational Sciences 09/18/17 - 06/30/22
Anthony J. Windebank, M.D., principal investigator A comprehensive combinatorial approach: modulation of the spinal cord microenvironment to induce regeneration using epidural stimulation with electrically conductive scaffolds containing genetically modified Schwann cells North American Spine Society 01/01/19 - 12/31/20
Anthony J. Windebank, M.D., principal investigator The application of ultrasound for assessment of nerve conduit repair in a clinical trial to test the safety of a novel polymer scaffold American Foundation for Surgery of the Hand 09/01/18 - 08/31/20
Anthony J. Windebank, M.D., principal investigator Spinal cord tissue regeneration through Schwann cell seeded hydrogel scaffolds with spatial-selective electrical stimulation Minnesota Office of Higher Education 07/02/18 - 06/30/20
Anthony J. Windebank, M.D., principal investigator The response of adipose-derived mesenchymal stromal cells to the intrathecal environment and correlations with therapeutic efficacy in patients with amyotrophic lateral sclerosis Regenerative Medicine Minnesota 03/01/19 - 02/29/20
Anthony J. Windebank, M.D., principal investigator CELLTOP: A Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis due to Traumatic Spinal Cord Injury Regenerative Medicine Minnesota 03/01/18 - 02/29/20
Anthony J. Windebank, M.D., principal investigator A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate Efficacy & Safety of Repeated Admin of NurOwn (Autologous MSC Secreting NTF) in Patients with ALS BrainStorm Cell Therapeutics 01/03/18 - 01/02/20
Anthony J. Windebank, M.D., principal investigator A comprehensive combinatorial approach: modulation of the spinal cord microenvironment to induce regeneration using epidural stimulation with electrically conductive scaffolds containing genetically modified Schwann cells Morton Cure Paralysis Fund 01/01/19 - 12/31/19
Anthony J. Windebank, M.D., principal investigator AFIRM II: Tissue engineering for repair of critical nerve gaps Department of Defense 01/01/14 - 12/31/19
Anthony J. Windebank, M.D., principal investigator Modulating The Spinal Cord Microenvironment And Sublesional Circuitry Using Epidural Stimulation With Electrically Conductive Hydrogel Scaffolds Seeded With Schwann Cells Minnesota Office of Higher Education 08/22/17 - 06/30/19
Anthony J. Windebank, M.D., principal investigator A cell-assembled matrix template to guide nerve regeneration in the spinal cord New Jersey Commission on Spinal Cord Research 06/29/15 - 06/28/19
Anthony J. Windebank, M.D., principal investigator Intrathecal Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Amyotrophic Lateral Sclerosis The Judith & Jean Pape Adams Charitable Foundation 12/31/15 - 12/30/18